How Alcohol Changes Your Endocannabinoid Levels and What That Means for How Drunk You Feel

Acute alcohol consumption decreased 2-AG concentrations compared to placebo. A drop in 2-AG was associated with less drug "liking" and fewer feelings of "friendliness." Under placebo conditions, rising 2-AG was associated with maintained feelings of "stimulation." Alcohol did not significantly affect anandamide levels.

Within-subjects, single-blind, placebo-controlled alcohol challenge study with 28 healthy social drinkers aged 20-35. Alcohol (0.6 g/kg) and placebo sessions were counterbalanced. Endocannabinoids were measured from blood plasma; subjective effects via BAES, DEQ, and POMS.

This is the first evidence that endocannabinoids may explain individual differences in how people experience alcohol's rewarding effects. People whose 2-AG drops more after drinking may find alcohol less pleasurable, potentially influencing their drinking patterns.

Understanding how the endocannabinoid system mediates alcohol's rewarding effects could lead to new treatments for alcohol use disorder. If 2-AG levels modulate how pleasurable alcohol feels, targeting this system could reduce alcohol's appeal.

Small sample (28 participants). Single acute alcohol dose does not capture chronic drinking effects. Peripheral blood endocannabinoid levels may not perfectly reflect brain levels. Social drinkers only, not people with alcohol use disorder.